Processa Pharmaceuticals, Inc.: which funds bought and sold
Institutions that bought and sold Processa Pharmaceuticals shares in Q2 2026, from the holdings they reported to the SEC on Form 13F for March 31, 2026 and June 30, 2026.
Between March 31, 2026 and June 30, 2026, 7 institutions that filed 13F reports for both quarters added to or opened positions in Processa Pharmaceuticals, and 3 cut or closed them. Together they added a net 78K shares, +43.8% on what they held at the start of the quarter. Active managers and hedge funds on our list were net buyers of 21K shares; index fund managers were net sellers of 2,818 shares (−5.8%). 4 opened a new position and 2 sold out entirely.
Bought, Q2 2026 7 institutions, 4 of them new holders Sold, Q2 2026 3 institutions, 2 of them sold out
Net change, all compared +78K shares (+43.8%)
Net change, active managers +21K shares (—), 1 bought, 0 sold
Buyers versus sellers
7 bought 4 3 sold
Active managers and hedge funds 1 bought · 0 sold · +21K
Index fund managers 0 bought · 1 sold · −2,818
Other institutions 6 bought · 2 sold · +59K
Biggest buyers
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Citadel Advisors LLC Hedge fund | +21K New position | 21K | $40,908 |
| Connective Capital Management, LLC | +15K +20.6% | 85K | $163,726 |
| Xtx Topco Ltd | +13K New position | 13K | $25,521 |
| Jane Street Group, LLC | +13K New position | 13K | $25,466 |
| Stonex Group Inc. | +11K New position | 11K | $29,623 |
| UBS Group AG | +5,263 +207.9% | 7,794 | $14,964 |
| Tower Research Capital LLC (TRC) | +1,581 +172.2% | 2,499 | $4,798 |
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Citadel Advisors LLC Hedge fund | +21K New position | 21K | $40,908 |
Biggest sellers
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Geode Capital Management, LLC Index funds | −2,818 −11.3% | 22K | $42,412 |
| Citigroup Inc | −14 Sold out | 0 | — |
| Wells Fargo & Company | −6 Sold out | 0 | — |
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| None of the active managers on our list. | |||
New positions
| Institution | Shares | Value June 30, 2026 |
|---|---|---|
| Citadel Advisors LLCHedge fund | 21K | $40,908 |
| Stonex Group Inc. | 11K | $29,623 |
| Xtx Topco Ltd | 13K | $25,521 |
| Jane Street Group, LLC | 13K | $25,466 |
Sold out
| Institution | Shares | Value March 31, 2026 |
|---|---|---|
| Citigroup Inc | 14 | $35 |
| Wells Fargo & Company | 6 | $15 |
Who holds the shares
- Institutions reporting
- 12
- Ten largest holders
- 99.0% of 13F-reported shares
- Index fund managers
- 17.9% of 13F-reported shares
- Active managers and hedge funds
- 8.3% of 13F-reported shares
| Type | Bought | Sold | New | Sold out | Net change in shares | Net % |
|---|---|---|---|---|---|---|
| Active managers and hedge funds | 1 | 0 | 1 | 0 | +21K | — |
| Index fund managers | 0 | 1 | 0 | 0 | −2,818 | −5.8% |
| Other institutions | 6 | 2 | 3 | 2 | +59K | +45.9% |
← Back to Processa Pharmaceuticals, Inc. · Insiders · Politicians